-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Praxis Precision Medicine, Raises Price Target to $760

Benzinga·12/09/2025 12:41:08
语音播报
Guggenheim analyst Yatin Suneja maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $540 to $760.